|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 47/50 | |
| C07K 14/195 | |||
| C12N 9/10 | |||
| C12N 1/21 | |||
| C12P 19/28 |
| (11) | Patento numeris | 3177325 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15766054.9 |
| Europos patento paraiškos padavimo data | 2015-08-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-06-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-04-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2015/068203 |
| Data | 2015-08-06 |
| (87) | Numeris | WO 2016/020499 |
| Data | 2016-02-11 |
| (30) | Numeris | Data | Šalis |
| 201462035360 P | 2014-08-08 | US |
| (72) |
FARIDMOAYER, Amirreza, CH
|
| (73) |
GlaxoSmithKline Biologicals S.A.,
Rue de l`Institut, 89, 1330 Rixensart,
BE
|
| (54) | MODIFIED HOST CELLS AND HYBRID OLIGOSACCHARIDES FOR USE IN BIOCONJUGATE PRODUCTION |
| MODIFIED HOST CELLS AND HYBRID OLIGOSACCHARIDES FOR USE IN BIOCONJUGATE PRODUCTION |